Abstract
Background New technologies are challenging for health systems because they usually impose a high financial burden for limited benefits. In a recent study for Portugal, we showed that technological innovation for ischemic heart disease (IHD) increased expenditures by 27% over the 1997–2012 period. The present study examines assesses the impact of technological changes in in-patient mortality and 30-days readmission for IHD over …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
